Form 4 for TECH Bio-Techne
Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001062993-23-020118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-03 | 2023-11-01 | TECH | Kelderman Kim | COO | A - Grant | $0.00 | +14.2K | 35.4K | +67% | $0 |
| D | 2023-11-03 | 2023-11-01 | TECH | Kelderman Kim | COO | A - Grant | $0.00 | +38.3K | 38.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-01 | A | A | 14,196 | $0.00 | 35,421 | D | — | — | (F1) Represents 14,196 shares of restricted stock for which risks of forfeiture lapse as to 4,732 shares on each of 11/1/2024, 11/1/2025 and 11/1/2026. |
| 2 | Derivative | Stock Options (Right to Buy) | 2023-11-01 | A | A | 38,252 | $0.00 | 38,252 | D | $52.83 · — to 2030-11-01 | 38,252 Common Stock | (F11) Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. |